Letter by Matthews et al Regarding Article, "Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes: Implications for the Cardiovascular Disease Specialist". Circulation Matthews, D. R., Perkovic, V., Mahaffey, K. W. 2018; 138 (6): 660-661

View details for DOI 10.1161/CIRCULATIONAHA.118.035717

View details for PubMedID 30354619